期刊
JOURNAL OF CONTROLLED RELEASE
卷 251, 期 -, 页码 49-67出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2017.02.020
关键词
Cancer therapy; Tumor endogenous environment; Nanosystems; Stimulus-responsive; Reversing multidrug resistance
资金
- Shanghai Talent Development Fund [201565]
- Shu Guang project
- Shanghai Municipal Education Commission
- Shanghai Education Development Foundation [15SG39]
- Shanghai Pujiang Program [16PJD044]
Multidrug resistance (MDR) is a major obstacle to successful cancer therapy, especially for chemotherapy. Endogenous stimulus-responsive nanosystems (ESRNs), which were developed on the basis of the pathophysiological characteristics of the endogenous tumor microenvironment, have emerged as an efficient cancer therapy and have played an increasingly important role particularly in combating MDR cancers. These nanosystems can control the drug-releasing pattern temporally and spatially and can improve the accumulation of chemotherapeutic agents in MDR tumors or cells. This review focuses on recently published literature about nanosystems with endogenous stimulus-responsive features to overcome MDR, and it discusses their design and stimulus sensitivity, as well as their in vitro and in vivo anti-tumor efficacy in MDR tumors and cells. (C) 2017 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据